news Researchers identify a potential remdesivir resistance mechanism in SARS-CoV-2 8 October 2020 | By Hannah Balfour (Drug Target Review) Exploring how the Ebola virus develops remdesivir resistance has highlighted a mutation that could allow SARS-CoV-2 to do the same.
news Interactive 3D model of SARS-CoV-2 surface released 25 September 2020 | By Victoria Rees (Drug Target Review) A new interactive map of the surface of SARS-CoV-2, featuring the Spike, Envelope and Membrane proteins, has been released for researchers to use.
news Beautyberry leaf could be the secret to combatting MRSA infections 17 July 2020 | By Hannah Balfour (Drug Target Review) A compound extracted from the leaf of the American beautyberry re-sensitised methicillin-resistant Staphylococcus aureus (MRSA) to beta-lactam antibiotics.
news Protective antibodies identified for rare polio-like disease in children 6 July 2020 | By Hannah Balfour (Drug Target Review) Researchers isolated monoclonal antibodies from children who has survived infection by EV-D68, the virus linked to acute flaccid myelitis (AFM). These antibodies protected mice against infection.
article Safer and more affordable medicine for all? How pharmacogenomics may level the playing field 16 March 2020 | By Drug Target Review Dr Mike Tocci discusses how pharmacogenomics can revolutionise medical research and improve the efficacy and quality of drugs.
news 3D visualisation of COVID-19 surface released for researchers 13 March 2020 | By Victoria Rees (Drug Target Review) A new 3D model of the surface of the coronavirus COVID-19 has been released, to aid researchers in the development of a treatment.